Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Workman

Showing results (31-40 of 3,059) with videos related to

Pageof 306
Sort By:
Advances in Experimental Medicine and Biology|April 17, 2020
Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal PerspectivePaul Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics in experimental and clinical chemotherapyP Workman
Nature|June 13, 2014
Academia and industry: Successes for UK cancer partnershipPaul Workman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 1998
Carcinogen-in-a-canS Workman
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|November 29, 2001
Guiding parents through the death of their infantE Workman
Drug Discovery Today|August 30, 2003
Paul Workman on the challenges of cancer drug development. Interview by Katharine E. PestellPaul Workman
Health Communication|August 3, 2010
The reluctant consumption of evidence-based decision makingThomas Workman
BMJ (Clinical Research Ed.)|March 10, 2007
Researching a good deathStephen Workman
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 18, 2020
The proportion of COVID-19 cases that are asymptomatic in South Korea: Comment on Nishiura et alJoseph Workman
Anti-Cancer Drug Design|November 20, 1997
Towards intelligent anticancer drug screening in the post-genome era?P Workman
Pageof 306

Showing results (31-40 of 3,059) with videos related to

Sort By:
Pageof 306
Advances in Experimental Medicine and Biology|April 17, 2020
Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal PerspectivePaul Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics in experimental and clinical chemotherapyP Workman
Nature|June 13, 2014
Academia and industry: Successes for UK cancer partnershipPaul Workman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 1998
Carcinogen-in-a-canS Workman
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|November 29, 2001
Guiding parents through the death of their infantE Workman
Drug Discovery Today|August 30, 2003
Paul Workman on the challenges of cancer drug development. Interview by Katharine E. PestellPaul Workman
Health Communication|August 3, 2010
The reluctant consumption of evidence-based decision makingThomas Workman
BMJ (Clinical Research Ed.)|March 10, 2007
Researching a good deathStephen Workman
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 18, 2020
The proportion of COVID-19 cases that are asymptomatic in South Korea: Comment on Nishiura et alJoseph Workman
Anti-Cancer Drug Design|November 20, 1997
Towards intelligent anticancer drug screening in the post-genome era?P Workman
Pageof 306